← All organizations
Highest phase reached
Phase 1
First clinical trial
Oct 19, 2017Last known activity
Feb 27, 2025
Timeline
2010s
- Jun 1, 2014
Oric Pharmaceuticals— Founded
Drugs by trial phase (7 distinct, 9 trials)
Phase 1 (7 own, 0 via acquisition)
Indications
Studied for
Recent trials (16)
- NCT06816992Lead sponsorPhase 1Feb 27, 2025
- NCT06816992OfficialPhase 1Feb 27, 2025
- NCT06012721Lead sponsorPhase 1Sep 11, 2023
- NCT06012721Study directorPhase 1Sep 11, 2023
- NCT05413421Lead sponsorPhase 1Jun 1, 2022
- NCT05413421Study directorPhase 1Jun 1, 2022
- NCT05315700Lead sponsorPhase 1Mar 10, 2022
- NCT05315700Study directorPhase 1Mar 10, 2022
- NCT05227144Study directorPhase 1Jan 6, 2022
- NCT05227144Lead sponsorPhase 1Jan 6, 2022
- NCT04033328Lead sponsorPhase 1Sep 30, 2019
- NCT04033328Study directorPhase 1Sep 30, 2019
- NCT03928314Study directorPhase 1May 2, 2019
- NCT03928314Lead sponsorPhase 1May 2, 2019
- NCT03835637Lead sponsorPhase 1Mar 23, 2018
Details
- Founded
- South San Francisco, CA, US Jun 1, 2014
- Last known activity
- Feb 27, 2025